The study of inducing anti-glioma activity in vitro with human autologous dendritic cell-based fusion cells

被引：0
|
作者：
Chen, Z [1 ]
Shi, H [1 ]
机构：
[1] Ctr Canc, Guangzhou, Peoples R China
来源：
NEURO-ONCOLOGY | 2005年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
349
引用
收藏
页码：371 / 371
页数：1
相关论文
共 50 条
  • [31] Novel dendritic cell-based in vitro system for the detection of autoreactive CD4+T cells in pemphigus
    Karlmark, K. R.
    Wittmann, E.
    Llamazares, M.
    Hertl, M.
    Schnare, M.
    Eming, R.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (03) : e33 - e33
  • [32] Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
    Takashi Morisaki
    Kotaro Matsumoto
    Hideya Onishi
    Hideo Kuroki
    Eishi Baba
    Akira Tasaki
    Makoto Kubo
    Mitsunari Nakamura
    Syoichi Inaba
    Koji Yamaguchi
    Masao Tanaka
    Mitsuo Katano
    Human Cell, 2003, 16 (4) : 175 - 182
  • [33] A Human Dendritic Cell-Based In Vitro Model to Assess Mycobacterium Tuberculosis SO2 Vaccine lmmunogenicity
    Etna, Marilena P.
    Giacomini, Elena
    Severa, Martina
    Pardini, Manuela
    Aguilo, Nacho
    Martin, Carlos
    Coccia, Eliana M.
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2014, 31 (04) : 397 - 406
  • [34] Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dendritic cell/melanoma cell hybridomas
    Soruri, A
    Fayyazi, A
    Neumann, C
    Schlott, T
    Jung, T
    Matthes, C
    Zwirner, J
    Riggert, J
    Peters, JH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (06) : 307 - 314
  • [35] Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations
    Tapia-Calle, Gabriela
    Stoel, Maaike
    de Vries-Idema, Jacqueline
    Huckriede, Anke
    VACCINES, 2017, 5 (03):
  • [36] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Hilko Ardon
    Stefaan Van Gool
    Isabel Spencer Lopes
    Wim Maes
    Raf Sciot
    Guido Wilms
    Philippe Demaerel
    Patricia Bijttebier
    Laurence Claes
    Jan Goffin
    Frank Van Calenbergh
    Steven De Vleeschouwer
    Journal of Neuro-Oncology, 2010, 99 : 261 - 272
  • [37] Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Ardon, Hilko
    Van Gool, Stefaan
    Lopes, Isabel Spencer
    Maes, Wim
    Sciot, Raf
    Wilms, Guido
    Demaerel, Philippe
    Bijttebier, Patricia
    Claes, Laurence
    Goffin, Jan
    Van Calenbergh, Frank
    De Vleeschouwer, Steven
    JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) : 261 - 272
  • [38] Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dendritic cell /melanoma cell hybridomas
    Afsaneh Soruri
    Afshin Fayyazi
    Christine Neumann
    Thilo Schlott
    Thomas Jung
    Constanze Matthes
    Joerg Zwirner
    Joachim Riggert
    J. Hinrich Peters
    Cancer Immunology, Immunotherapy, 2001, 50 : 307 - 314
  • [39] NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells
    Yu, Zhiyun
    Xie, Guifang
    Zhou, Guangtong
    Cheng, Ye
    Zhang, Guangtao
    Yao, Guangming
    Chen, Yong
    Li, Yunqian
    Zhao, Gang
    CANCER LETTERS, 2015, 367 (01) : 58 - 68
  • [40] Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
    Dey, Mahua
    Chang, Alan L.
    Miska, Jason
    Wainwright, Derek A.
    Ahmed, Atique U.
    Balyasnikova, Irina V.
    Pytel, Peter
    Han, Yu
    Tobias, Alex
    Zhang, Lingjiao
    Qiao, Jian
    Lesniak, Maciej S.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (01): : 367 - 376
12345